These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11558712)

  • 1. Growth in prescription drug spending among insured elders.
    Thomas CP; Ritter G; Wallack SS
    Health Aff (Millwood); 2001; 20(5):265-77. PubMed ID: 11558712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond survey data: a claims-based analysis of drug use and spending by the elderly.
    Steinberg EP; Gutierrez B; Momani A; Boscarino JA; Neuman P; Deverka P
    Health Aff (Millwood); 2000; 19(2):198-211. PubMed ID: 10718034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic conditions and disabilities: trends and issues for private drug plans.
    Boccuti C; Moon M; Dowling K
    Policy Brief Commonw Fund; 2003 Oct; (680):1-10. PubMed ID: 14562797
    [No Abstract]   [Full Text] [Related]  

  • 5. [The pharmaceutical cost of elderly people in private health insurance].
    Wild F
    Versicherungsmedizin; 2009 Dec; 61(4):159-62. PubMed ID: 20052826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explaining drug spending trends: does perception match reality?
    Dubois RW; Chawla AJ; Neslusan CA; Smith MW; Wade S
    Health Aff (Millwood); 2000; 19(2):231-9. PubMed ID: 10718037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plans confront specialty pharmacy's escalating costs in variety of ways.
    Reinke T
    Manag Care; 2010 Dec; 19(12):12-3, 15-6, 19. PubMed ID: 21291126
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
    Pauly NJ; Brown JD
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Health Spending In 2014: Faster Growth Driven By Coverage Expansion And Prescription Drug Spending.
    Martin AB; Hartman M; Benson J; Catlin A;
    Health Aff (Millwood); 2016 Jan; 35(1):150-60. PubMed ID: 26631494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.
    Lillard LA; Rogowski J; Kington R
    Med Care; 1999 Sep; 37(9):926-36. PubMed ID: 10493470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription drugs: recent trends in utilization, expenditures, and coverage.
    Sethi RC
    EBRI Issue Brief; 2004 Jan; (265):1-35. PubMed ID: 14969223
    [No Abstract]   [Full Text] [Related]  

  • 12. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program.
    Anderson GM; Kerluke KJ; Pulcins IR; Hertzman C; Barer ML
    Inquiry; 1993; 30(2):199-207. PubMed ID: 8314608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medication supply of privately insured patients in 2010].
    Wild F
    Versicherungsmedizin; 2012 Jun; 64(2):85-6. PubMed ID: 22808648
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescription drugs and the changing concentration of health care expenditures.
    Zuvekas SH; Cohen JW
    Health Aff (Millwood); 2007; 26(1):249-57. PubMed ID: 17211035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.
    Cecil WT; Barnes J; Shea T; Coulter SL
    J Manag Care Pharm; 2006 Oct; 12(8):665-76. PubMed ID: 17269845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing prescribing patterns and increasing prescription expenditures in Medicaid.
    Fink KS; Byrns PJ
    Ann Fam Med; 2004; 2(5):488-93. PubMed ID: 15506586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
    Johnson JT; Neill KK; Davis DA
    J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A decade of increases in Medicare Part B pharmaceutical spending: what are the drivers?
    San-Juan-Rodriguez A; Gellad WF; Shrank WH; Good CB; Hernandez I
    J Manag Care Spec Pharm; 2021 May; 27(5):565-573. PubMed ID: 33908276
    [No Abstract]   [Full Text] [Related]  

  • 20. Americans' access to prescription drugs stabilizes, 2007-2010.
    Boukus ER; Carrier ER
    Track Rep; 2011 Dec; (27):1-5. PubMed ID: 22180943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.